We’re barely into the third quarter, yet it’s already clear this will be a year unlike any other.
Ventas, Welltower comment on COVID-19; Genesis reports 4th-quarter loss
By
Amy Novotney
Mar 18, 2020
The CEOs of two large senior housing real estate investment trusts reassured their residents, staff and investors Tuesday that the companies are prioritizing resident and staff health and safety above...
US health officials urge indoor masking in major cities as ‘tripledemic’ rages
Dec 12, 2022
During the past few weeks, COVID-19, the flu and respiratory syncytial virus have made millions of Americans ill.
FDA could approve Pfizer booster shots for all adults this week
Nov 17, 2021
More than 30 million Americans already have gotten booster shots.
No sign Supreme Court will block COVID-19 vaccination mandates, legal expert say
By
Kathleen Steele Gaivin
Dec 15, 2021
The U.S. Supreme Court declined Monday in a 6-3 ruling to hear a challenge to New York’s vaccine mandate for healthcare workers on religious grounds, and a legal expert says evidence is mounting that...
COVID-19 vaccination may increase risk for urinary tract symptoms
Aug 01, 2024
A higher proportion of those who received a single dose versus three doses had to urinate five or more times in the night.
Flu season ramping up with variant identified as dangerous to older adults: CDC
By
Kimberly Bonvissuto
Dec 03, 2021
This year’s flu season is gaining traction with a strain that is especially dangerous for older adults, according to the Centers for Disease Control and Prevention.
COVID-19 public health emergency extended again, maybe for the last time
By
Lois A. Bowers
Jan 11, 2023
The public health emergency due to COVID-19 has been renewed again for what many experts believe will be the last time.
$3 trillion HEROES Act passes in House with provisions for senior living, but Senate prospects dim
By
Lois A. Bowers
May 18, 2020
Although it remains to be seen whether the HEROES Act reaches the president’s desk, five provisions of the original or House-passed bill have a chance of becoming law, according to one source. Read other...
FDA questions strength of Johnson & Johnson booster shot data
Oct 13, 2021
The agency says a key test used by the company to measure immune response from booster shot six months after the original shot was likely not sensitive enough.